Statement from the Council of Chief Medical Officers of Health and the Chief Coroners and Chief Medical Examiners - Latest National Data on Substance-Related Harms Français
OTTAWA, ON, June 25, 2025 /CNW/ - The overdose crisis, driven by a toxic illegal drug supply, is one of the most serious public health crises our country has ever faced. Powerful drugs like fentanyl and other synthetic opioids have been flooding the illegal drug supply. The drug toxicity crisis, driven by the toxic drug supply, is a serious public health crisis, with pervasive impacts on families and communities across Canada. The tragic impacts are seen and felt among our friends, our families, and our neighbours.
Today's data release provides a picture of substance-related deaths and harms in 2024. From January to December 2024, there were 7,146 opioid-related drug toxicity deaths, 5,514 hospitalizations, 36,266 Emergency Medical Services responses, and 24,587 emergency department visits.
The national data show substantial decreases for 2024 compared with 2023, while still very high compared to previous years, with a 17% decrease in the number of opioid-related deaths.
These national trends mask important regional differences, as each community faces its own unique challenges. While British Columbia, Alberta, Saskatchewan, Ontario, New Brunswick, and Yukon all reported decreases in opioid-related deaths between 2023 and 2024, Manitoba, Nova Scotia and Prince Edward Island saw little or no change. The Northwest Territories, Quebec, and Newfoundland and Labrador reported increases in opioid-related deaths over this period. Due to colonialization and continued marginalization, many Indigenous communities have also experienced increases in deaths and disproportionate harms, particularly among Indigenous women.
Understanding the drivers of increases and decreases, as well as regional and demographic dynamics is important for tailoring prevention and intervention strategies. Some provincial and territorial public health partners note that the decrease in deaths may be attributable- at least in part- to a shift to lower toxicity of the drug supply, based on drug checking data indicating a decrease in fentanyl concentrations. Notably, some regions reported a rise in deaths involving substances other than opioids, such as stimulants or benzodiazepines.
In 2024, an average of 20 people died every day from opioid toxicity in Canada, representing a tremendous loss. All aspects of our strategies to respond to the drug toxicity crisis should be population and person-centered. This includes working together across prevention, treatment, harm reduction, and enforcement to provide solutions. The drug toxicity crisis is complex, and continued coordinated efforts between multi-sectoral partners are key to save lives and improve population health.
Since 2016, pan-Canadian work has been underway to collaboratively build a national surveillance system to characterize the magnitude of the drug toxicity crisis and its impact on Canadian communities. Death investigation services collect crucial information that helps us understand the evolving nature of the crisis and inform public health action. Ongoing collaboration is essential to identify emerging needs, protective and risk factors, and to assess health inequities experienced by those disproportionately impacted by this urgent crisis.
As key partners in national surveillance related to opioid and stimulant-related deaths and harms, the provincial and territorial Chief Medical Officers of Health, and the Chief Coroners and Chief Medical Examiners 1 2 issued this joint statement to accompany the release of the latest data.
The Council of Chief Medical Officers of Health includes the Chief Medical Officer of Health from each provincial and territorial jurisdiction, Canada's Chief Public Health Officer, the Chief Medical Officer of Public Health of Indigenous Services Canada, the Chief Medical Officer from the First Nations Health Authority., and ex-officio members from other federal government departments.
Provincial and territorial Chief Coroners and Chief Medical Examiners oversee investigations into unexpected, unnatural, or unexplained deaths. Their role is crucial in determining the cause and understanding circumstances surrounding such deaths. Their work contributes to enhancing health and safety by informing legal and health policies.
With the exception of the Chief Medical Officer of Health of Alberta.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
13 hours ago
- Global News
Opioid deaths in Canada fell 17% but 20 people still died per day in 2024
An average of 20 Canadians died from an opioid overdose every day last year, federal health officials say, despite opioid-related drug toxicity deaths falling 17 per cent from the year before. The data for 2024 released Wednesday by the Public Health Agency of Canada showed 7,146 deaths were recorded last year. Eighty per cent of those occurred in just three provinces — British Columbia, Alberta and Ontario — although all three jurisdictions saw decreases from 2023. Increased deaths in 2024 compared to the year prior were reported in Quebec, the Northwest Territories and Newfoundland and Labrador, according to a joint statement from the country's chief medical officers of health, chief coroners and chief medical examiners. 'Due to colonialization and continued marginalization, many Indigenous communities have also experienced increases in deaths and disproportionate harms, particularly among Indigenous women,' the statement said. Story continues below advertisement Manitoba, Nova Scotia and Prince Edward Island saw 'little or no change' in deaths between 2023 and 2024, while all other provinces and territories saw decreases. Hospitalizations related to opioid poisoning also declined in 2024 by 15 per cent, with 5,514 patients nationwide. There were 24,587 emergency room visits and 36,266 responses by emergency first responders to suspected opioid-related overdoses last year, both also down by about 15 per cent on average. 0:32 B.C. releases toxic drug death data from 2024 The statement from health officials noted some provinces and territories believe the decreases in deaths 'may be attributable — at least in part — to a shift to lower toxicity of the drug supply, based on drug checking data indicating a decrease in fentanyl concentrations.' Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Fentanyl still accounted for about three-quarters of all opioid-related deaths in 2024, according to the data. While that rate is up from just over 40 per cent in 2016, it appears to have stabilized in recent years. Story continues below advertisement Between January 2016 and December 2024, a total of 52,544 apparent opioid toxicity deaths were reported, according to federal data. 'In 2024, an average of 20 people died every day from opioid toxicity in Canada, representing a tremendous loss,' Wednesday's statement said. 'Notably, some regions reported a rise in deaths involving substances other than opioids, such as stimulants or benzodiazepines.' 3:59 Health Matters: Stimulants increasingly detected among drug toxicity deaths Overdose deaths in the United States also declined by double digits last year. An estimated 80,000 people died from overdoses last year, according to provisional Centers for Disease Control and Prevention data released in May. That's down 27 per cent from the 110,000 in 2023 — the largest one-year decline ever recorded. Public health and drug policy experts have attributed the sharp decline to increased availability of the overdose-reversing drug naloxone, expanded addiction treatment and a shift away from drugs by young people after waves of deaths among older users. Story continues below advertisement Those experts have also pointed to the growing impact of over US$50 billion in money won through settlements of lawsuits against opioid manufacturers like Purdue Pharma, as well as consulting firms like McKinsey & Company that U.S. states alleged advised drugmakers on how to boost their sales. Several states have been directing that money toward recovering health-care costs, as well as funding addiction treatment programs, overdose prevention sites, anti-drug education and other initiatives. The latest such settlement was reached earlier this month between 55 U.S. state and territory attorneys general and Purdue, which agreed along with members of the Sackler family to pay US$7.4 billion. Local governments and individual victims will have until Sept. 30 to approve the settlement. B.C., which declared a public health emergency for the overdose crisis in 2016, has led several similar class-action lawsuits on behalf of the federal, provincial and territorial governments against drugmakers. It won $150 million from Purdue in a settlement first announced in 2022, and additional lawsuits were certified in court this year. McKinsey has denied it did any work in Canada to enhance the sale or marketing of opioids. The Canadian lawsuit against the firm alleges Canadian subsidiaries of Purdue and other drugmakers used the same tactics as the American companies McKinsey allegedly advised. —With files from the Associated Press
Cision Canada
14 hours ago
- Cision Canada
Predictive Success Celebrates 20 Years as Elite Partner of The Predictive Index® and Global Leadership in Talent Optimization
WHITBY, ON, June 25, 2025 /CNW/ - Predictive Success Corporation, a proud Canadian company and longtime Elite Partner of The Predictive Index ®, is celebrating 20 years of empowering organizations across North America to optimize their talent, strengthen teams, and drive performance through science-based people analytics. As the largest Predictive Index (PI) partner in number of total clients globally, Predictive Success has more organizations under subscription than any other firm in the PI network. Each year, Predictive Success trains over 1,000 leaders, and to date has certified more than 15,000 leaders as Predictive Index analysts—transforming the way businesses hire, lead, and scale across industries. "Predictive Success has been a remarkable ambassador of The Predictive Index for two decades," said Rabih Shanshiry, SVP at The Predictive Index. "Their consistency, client-first approach, and elite performance are unmatched." John McGuinnes, CFO of The Predictive Index, added, "Dave and his team embody what it means to build high-performing teams. We look forward to the next 20 years of growth together." Serving clients coast to coast in Canada and throughout the United States, Predictive Success provides consulting and training in both official languages. Its client roster includes leaders from industries ranging from healthcare and manufacturing to tech, professional sports, and public service. "Twenty years ago, we set out with a belief that great companies are built by great people—and great data," said Dave Lahey, Founder and CEO of Predictive Success. "Today, we are proud to be the most trusted PI partner worldwide, helping our clients unlock the full potential of their teams." Beyond business, Predictive Success is committed to giving back. The company proudly supports and Princess Margaret Cancer Centre, where it funds an immunotherapy research associate annually. Predictive Success is also a corporate award recipient from Ronald McDonald House Charities in both Markham and Toronto, recognizing ongoing contributions to families in need. The company's impact has not gone unnoticed. Predictive Success is a three-time recipient of the Profit 500 Growth Award, and a former Globe and Mail Top 400 Growth Company in Canada. As Predictive Success enters its third decade, it continues to innovate at the forefront of talent optimization—integrating AI, people analytics, and leadership science to build thriving workplaces.
Cision Canada
14 hours ago
- Cision Canada
Public Advisory - Buying health products online? Know the risks Français
Summary Product: Unauthorized health products, including drugs, natural health products and medical devices, sold on the Internet Issue: Health products – Product safety; Unauthorized product What to do: If you buy health products online, buy them from a reputable website and check that Health Canada has authorized them for sale. Report suspected illegal health products to Health Canada. Affected products Drugs, natural health products, and medical devices that have not been authorized by Health Canada and may pose serious health risks. Issue As part of Operation Pangea XVII —an international effort led by INTERPOL to disrupt the online sale of counterfeit medicines and other illegal health products around the world—Health Canada is reminding consumers to be careful when buying health products—including drugs, natural health products and medical devices—over the Internet. Health products sold online may seem legitimate and safe, but some may not actually be authorized for sale in Canada and could be dangerous to your health. It is important to know how to spot risky health products if you are buying them online. Unauthorized health products have not been assessed by Health Canada for safety, efficacy, and quality and as a result, can pose serious risks to your health. For example, they may be fake, badly stored, mislabeled, expired, or subject to recalls. Unauthorized drugs or natural health products may have no active ingredients, the wrong ingredients, or dangerous additives such as prescription drugs not listed on the label. Unlicensed medical devices might be low quality, may not work, or may be unsafe. During this year's five-month Operation (December 16, 2024, to May 16, 2025), Health Canada inspected 19,193 packages. Of these, it stopped 7,096 (37%) packages from entering the country and seized 539 (3%) additional packages at the border that contained suspected counterfeit or otherwise unauthorized health products, worth an estimated total value of $378,170. The vast majority of the seized products were sexual enhancement medications (69%), followed by supplements such as herbal and dietary supplements (10%), veterinary and antiparasitic drugs (4%), hormones (2%), antibiotics (2%) and weight loss drugs (1%). Health Canada works with the Royal Canadian Mounted Police and the Canada Border Services Agency (CBSA) during Operation Pangea to stop counterfeit and other illegal health products from reaching the Canadian market and to help raise consumer awareness. Health Canada works in partnership with CBSA throughout the year to detect and stop unauthorized health products from entering the country. What you should do Read the information Health Canada has posted on the dangers of buying drugs, natural health products or medical devices over the Internet. Look for health products that have been authorized by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM). Consumers can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database, Licensed Natural Health Products Database or Medical Devices Active Licence Listing (MDALL). Avoid buying health products from questionable or untrustworthy websites. Find out more about choosing a safe online pharmacy. If you have questions about whether an online pharmacy is legitimate, contact the pharmacy regulatory authority in your province or territory. Talk to a health care professional, such as a doctor or pharmacist, if you have questions or concerns about a health care product. Check Health Canada's Recalls and Safety Alerts database for advisories on illegal health products that have been found on the Canadian market. Health Canada maintains lists of unauthorized sexual enhancement products, skin lightening and other skin treatments, workout supplements and poppers that consumers can check regularly for updates. Report adverse events or complaints involving drugs, natural health products or medical devices, including illegal health products, to Health Canada. Related links INTERPOL news release Counterfeit prescription drugs Buying drugs over the Internet Choosing a safe online pharmacy How to spot an unsafe online store Safe use of body building products Adulteration of natural health products Buying safe sexual enhancement products The safe use of health products for weight loss Alert / recall type: Public Advisory Category: Health products – Drugs, Natural Health Products, Medical Device Published by: Health Canada Également disponible en français SOURCE Health Canada (HC) Media Enquiries: Health Canada, 613-957-2983, [email protected]; Public Enquiries: 613-957-2991, 1-866 225-0709, [email protected]
